Cargando…
Could Nanotheranostics be the Answer to the Coronavirus Crisis?
The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly dia...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182285/ https://www.ncbi.nlm.nih.gov/pubmed/34141446 http://dx.doi.org/10.1002/gch2.202000112 |
_version_ | 1783704177440980992 |
---|---|
author | Mosselhy, Dina A. Assad, Mhd Adel Sironen, Tarja Elbahri, Mady |
author_facet | Mosselhy, Dina A. Assad, Mhd Adel Sironen, Tarja Elbahri, Mady |
author_sort | Mosselhy, Dina A. |
collection | PubMed |
description | The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly diagnose COVID‐19 under the umbrella of nanotheranostics (i.e., smart, single agents combining nanodiagnostics and nanotherapeutics) are elaborated. The present work provides new insights into the promising incorporation of antiviral nanotheranostics into nanostructured materials, including electrospun fibers with tailored pore sizes and hydrophobicity, namely “superhydrophobic self‐disinfecting electrospun facemasks/fabrics (SSEF).” SSEFs are proposed as smart alternatives to address the drawbacks of N95 respirators. The challenges of coronavirus containment are underscored, literature is reviewed, and “top‐five suggestions” for containing COVID‐19 are offered, including: i) preventive appraisals—avoiding needless hospital admission and practicing frequent hand washing (from 20 to 60 s). ii) Diagnostics—highly recommending nanodiagnostics, detecting COVID‐19 within 10 min. iii) Therapeutics—expanding nanotherapeutics to treat COVID‐19 and bacterial co‐infections after safety assessments and clinical trials. iv) Multipronged and multinational, including China, collaborative appraisals. v) Humanitarian compassion to traverse this pandemic in a united way. |
format | Online Article Text |
id | pubmed-8182285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81822852021-06-16 Could Nanotheranostics be the Answer to the Coronavirus Crisis? Mosselhy, Dina A. Assad, Mhd Adel Sironen, Tarja Elbahri, Mady Glob Chall Reviews The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly diagnose COVID‐19 under the umbrella of nanotheranostics (i.e., smart, single agents combining nanodiagnostics and nanotherapeutics) are elaborated. The present work provides new insights into the promising incorporation of antiviral nanotheranostics into nanostructured materials, including electrospun fibers with tailored pore sizes and hydrophobicity, namely “superhydrophobic self‐disinfecting electrospun facemasks/fabrics (SSEF).” SSEFs are proposed as smart alternatives to address the drawbacks of N95 respirators. The challenges of coronavirus containment are underscored, literature is reviewed, and “top‐five suggestions” for containing COVID‐19 are offered, including: i) preventive appraisals—avoiding needless hospital admission and practicing frequent hand washing (from 20 to 60 s). ii) Diagnostics—highly recommending nanodiagnostics, detecting COVID‐19 within 10 min. iii) Therapeutics—expanding nanotherapeutics to treat COVID‐19 and bacterial co‐infections after safety assessments and clinical trials. iv) Multipronged and multinational, including China, collaborative appraisals. v) Humanitarian compassion to traverse this pandemic in a united way. John Wiley and Sons Inc. 2021-03-24 /pmc/articles/PMC8182285/ /pubmed/34141446 http://dx.doi.org/10.1002/gch2.202000112 Text en © 2021 The Authors. Global Challenges published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Mosselhy, Dina A. Assad, Mhd Adel Sironen, Tarja Elbahri, Mady Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title | Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title_full | Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title_fullStr | Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title_full_unstemmed | Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title_short | Could Nanotheranostics be the Answer to the Coronavirus Crisis? |
title_sort | could nanotheranostics be the answer to the coronavirus crisis? |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182285/ https://www.ncbi.nlm.nih.gov/pubmed/34141446 http://dx.doi.org/10.1002/gch2.202000112 |
work_keys_str_mv | AT mosselhydinaa couldnanotheranosticsbetheanswertothecoronaviruscrisis AT assadmhdadel couldnanotheranosticsbetheanswertothecoronaviruscrisis AT sironentarja couldnanotheranosticsbetheanswertothecoronaviruscrisis AT elbahrimady couldnanotheranosticsbetheanswertothecoronaviruscrisis |